Winningham Rick E bought TBPH
April 1, 2026 · Form 4 insider transaction
Winningham Rick E bought 75,000 shares of Theravance Biopharma, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
75,000
Price
$0.00
Total value
N/A
InsiderWinningham Rick E
RoleOfficer, Director
SecurityOrdinary Shares
Transaction codeA: Grant or award
Transaction dateApril 1, 2026
Filing dateApril 3, 2026
Shares owned after1,651,094
OwnershipDirect
10b5-1 planNo
AmendedNo